The expression of RP2 in GBMLGG was positively related with TMB, suggesting that high expression of RP2 may promote the development of cancer by affecting gene mutations in glioma, meanwhile, a low mutation rate is not conducive to immunotherapy (Figure 11B). Here, RP2 is linked to cancer.